Literature DB >> 3126141

Use of transformation to construct Neisseria gonorrhoeae strains with altered lipooligosaccharides.

D C Stein1, E F Petricoin, J M Griffiss, H Schneider.   

Abstract

DNA isolated from a nalidixic acid- and rifampin-resistant derivative of Neisseria gonorrhoeae serum-resistant strain 302 (MUG116), a strain that reacts with monoclonal antibody (MAb) 2-1-L8, was used to transform N. gonorrhoeae DOV, a serum-sensitive strain, to antibiotic resistance and/or reactivity with the MAb. MAb 2-1-L8 binds to a 3.6-kilodalton lipooligosaccharide (LOS). Reactivity with MAb 2-1-L8 transformed as a single marker and was unlinked to either of the antibiotic resistance markers. Immunoblot analysis of LOSs separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that new LOSs were synthesized in the transformed cells and that these LOSs corresponded to those of the DNA donor. Although multiple LOS components were made by the transformants, the MAb recognized only one. All transformants that were selected for on the basis of strong reactivity with MAb 2-1-L8 were serum resistant; however, the level of resistance correlated with the apparent loss of recipient LOS components. MAb 2-1-L8-reactive transformants that still produced DOV LOS components remained serum sensitive.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126141      PMCID: PMC259367          DOI: 10.1128/iai.56.4.762-765.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  The surface properties of Neisseria gonorrhoeae: determinants of susceptibility to antibody complement killing.

Authors:  M E Ward; P R Lambden; J E Heckels; P J Watt
Journal:  J Gen Microbiol       Date:  1978-10

2.  Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose.

Authors:  H Sidberry; B Kaufman; D C Wright; J Sadoff
Journal:  J Immunol Methods       Date:  1985-02-11       Impact factor: 2.303

3.  A spontaneous mutant of Neisseria gonorrhoeae with decreased resistance to neutrophil granule proteins.

Authors:  W M Shafer; V Onunka; P J Hitchcock
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.

Authors:  P A Rice; D L Kasper
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

6.  Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis.

Authors:  H Schneider; T L Hale; W D Zollinger; R C Seid; C A Hammack; J M Griffiss
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Studies on lipopolysaccharides isolated from strains of Neisseria gonorrhoeae.

Authors:  A Stead; J S Main; M E Ward; P J Watt
Journal:  J Gen Microbiol       Date:  1975-05

8.  Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa.

Authors:  C R Gregg; M A Melly; C G Hellerqvist; J G Coniglio; Z A McGee
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Immunological basis of serum resistance of Neisseria gonorrhoeae.

Authors:  H Schneider; J M Griffiss; G D Williams; G B Pier
Journal:  J Gen Microbiol       Date:  1982-01

10.  Characterization of a chimeric beta-lactamase plasmid of Neisseria gonorrhoeae which can function in Escherichia coli.

Authors:  D C Stein; F E Young; F C Tenover; V L Clark
Journal:  Mol Gen Genet       Date:  1983
View more
  14 in total

1.  Structure-function studies of the Neisseria gonorrhoeae major outer membrane porin.

Authors:  Adrienne Chen; H Steven Seifert
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

Review 2.  Introduction of cloned genes into Neisseria gonorrhoeae.

Authors:  D C Stein
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 3.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  The transcriptome response of Neisseria gonorrhoeae to hydrogen peroxide reveals genes with previously uncharacterized roles in oxidative damage protection.

Authors:  Elizabeth A Stohl; Alison K Criss; H Steven Seifert
Journal:  Mol Microbiol       Date:  2005-10       Impact factor: 3.501

5.  Molecular analysis of lipooligosaccharide biosynthesis in Neisseria gonorrhoeae.

Authors:  E F Petricoin; D C Stein
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.

Authors:  L D Cope; R Yogev; J Mertsola; J C Argyle; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

7.  The identification of cryptic rhamnose biosynthesis genes in Neisseria gonorrhoeae and their relationship to lipopolysaccharide biosynthesis.

Authors:  B D Robertson; M Frosch; J P van Putten
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

Authors:  D C Stein; R J Danaher; T M Cook
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

9.  Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.

Authors:  R J Danaher; J C Levin; D Arking; C L Burch; R Sandlin; D C Stein
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

10.  A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression.

Authors:  E S Drazek; D C Stein; C D Deal
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.